Portfolio company
Lucira Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company manufactures disposable molecular diagnostic kits for infectious diseases including COVID-19 and influenza for healthcare providers and consumers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cue Health
This company manufactures portable molecular diagnostic systems for at-home and clinical testing of infectious diseases for individuals and healthcare providers.
Readily
This company develops rapid molecular diagnostic tests for infectious diseases for healthcare providers and patients without access to laboratory infrastructure.
Visby Medical
This company develops portable, single-use molecular diagnostic devices for clinicians and consumers to detect infectious diseases, including respiratory and sexual health conditions.
NOWDiagnostics
This company develops and manufactures rapid over-the-counter and point-of-care diagnostic tests for consumers and healthcare professionals.
Inflammatix
This company develops point-of-care molecular diagnostic tests for healthcare providers to identify acute infections and sepsis by reading the body's immune response.
Astute Medical
This company develops in vitro diagnostic tests for hospitals and laboratories to identify sepsis, infectious diseases and other medical conditions.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
Molecular Designs
The company develops and manufactures multiplex PCR assays and nucleic acid extraction systems for clinical laboratories and research institutions.
